The Lipid Panel
The Lipid Panel is a monthly series hosted live on the last Tuesday of each month at 8PM Eastern Time. The webcast series features unique case discussions on a variety of topics in the field of lipidology, presented and discussed by a panel of expert faculty.
We are excited to have offered a virtual educational series featuring multiple episodes in combination with NLA leadership and our industry partners. This virtual series celebrating National Cholesterol Education Month is now available and offered at no charge for all. Experts in the field of Lipidology cover content on specific topic in the field, some presentations also contain a presentation by one of our industry partner with relevant clinical trial(s) information in that area.
National Lipid Association
The NLA Journal Club is a series of free webinars designed to keep lipidologists up-to-date on the newest topics and techniques in Clinical Lipidology. Each webinar will include a short presentation and focused discussion from one of our senior members on the chosen journal/publication.
Online Lipid Education Activities
Lipid Education Online is a user-friendly, tech-savvy adaptation of the NLA's live training courses. The National Lipid Association's outstanding live courses are reproduced here in a self-paced, mobile-friendly and interactive online learning experience, especially designed to give you all the tools you need to pursue lipidology as a full-fledged lipid specialist or to enhance your existing practice of medicine.
NLA Self Assessment Program
The NLA-SAP series is a comprehensive, interactive clinical problem-solving program that validates, strengthens and reinforces your knowledge of the core curriculum of clinical lipidology. The program provides a critical assessment of your strengths and weaknesses to guide you in the selection of additional CME training courses.
Complex Lipid Management Self Assessment Program
During this activity, Dr. Nihar Desai and Dr. Alan Brown discuss their top 10 takeaway messages from the National Lipid Association’s 2019 Fall Clinical Lipid Update. Tune in to learn more about the use of coronary calcium scoring and advances in lipid laboratory measurements.
2019 Fall Clinical Lipid Update: Top 10 Takeaways
During this activity, Dr. Nihar Desai and Dr. Alan Brown discuss their top 10 takeaway messages from the National Lipid Association’s 2019 Fall Clinical Lipid Update. Tune in to learn more about the use of coronary calcium scoring and advances in lipid laboratory measurements
Guess the Diagnosis: Uncommon Cases Presenting Commonly
Tune in to this on-demand activity from the NLA’s Clinical Lipid Update in Minneapolis! Test your knowledge of uncommon lipid disorders as you diagnose two virtual patients and workshop their cases along with our experts.
Triglyceride Activity Center
Your home for triglyceride education! The Triglyceride Activity Center features activities and resources to strengthen your knowledge of triglyceride lowering, EPA and DHA, clinical trials and their implications for your patients, and patient-centered cardiovascular risk assessment.
Past Meeting Highlights
The NLA takes pride in our speakers, so much so that we've built up a library of clinical lipidology talks, presentations, and case studies from past years. A great benefit of being an NLA member is that you have the ability to watch talks and presentations from our past conferences online.
Tune in quarterly and hear from Dr. Alan Brown as he talks with expert speakers to gain insights on some of the leading topics in the field of lipidology.
Successful Dyslipidemia Management: Tips and Tricks to Overcome Access Issues
This accredited program will feature a 15-minute expert discussion on the gaps present in dyslipidemia management, the impact of formulary/access issues on these gaps, and strategies for overcoming access issues in dyslipidemia.
Combating Residual Risk with Treatment Intensification: Focus on PCSK9 Inhibitors - A Care Team Forum℠
This activity features an engaging video panel discussion with 3 renowned clinical experts and Charles—a patient living with familial hypercholesterolemia (FH). The lively exchange is enhanced with explanatory visuals; direct note-taking capability; interactive questions; and a full in-suit resource library. The panel will delve into topics covering safety/efficacy data for PCSK9 inhibitors (PCSK9-Is), 2018 ACC/AHA guideline updates, and patient selection for treatment intensification with PCSK9-Is. Faculty will examine key matters in patient care, provide illustrative patient case scenarios, pose practical solutions to common issues encountered in clinical practice, and Charles will provide insight into his experience with FH, its treatment, and his interaction with the healthcare system.
Obtaining Authorization for Use of PCSK9 Inhibitors: A Care Team Forum℠
It took a lot of convincing for Charles to get back on medication to help lower his cholesterol—particularly because his mother, who also had high cholesterol, lived to be 100 years old. He was later diagnosed with familial hypercholesterolemia (FH) and started on a PCSK9 inhibitor (PCSK9-I) after failing several statin and non-statin therapies. Within weeks, he found himself both astounded at its efficacy but also its cost. In this interactive roundtable discussion, Charles, his doctor, and 2 other prominent clinical experts gather to deliberate over reimbursement issues surrounding the clinical use of PCSK9-Is and offer practical strategies to facilitate navigating the prior authorization and appeals process.
Free CME/CE Activity on Emerging Therapeutics in FH
This live symposium held in conjunction with the 2018 NLA Spring Clinical Update will explore and analyze data in specific patient populations in PCSK9 Inhibitor Therapeutics. Expert faculty will give updates on recent PCSK9 inhibitor data and dive into how to optimally apply these therapies into clinical practice. Recent dyslipidemia guidelines will also be reviewed. The panel will discuss how to best improve outcomes for dyslipidemia patients, including those with stroke or at high CV risk.
This page was last updated: Nov 15, 2022